Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Past Funding Opportunities

right
Deadline: 
Monday, November 4, 2019 - 5:00pm
The Columbia Life Science Accelerators: Lab-to-Market Programs are now accepting pre-proposal applications for their 2019-2020 awards cycle.
right
Deadline: 
Monday, October 21, 2019 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.

right
Deadline: 
Monday, August 26, 2019 - 5:30pm to Monday, September 30, 2019 - 5:30pm

Almirall, S.A. is looking to sponsor research collaborations investigating novel targets, pathways, or therapeutic candidates relating to chronic immune-inflammatory diseases. Academics and university departments are invited to submit relevant, non‑confidential research proposals using the application form linked below. The team at Almirall are interested in sponsoring early-stage research programmes focused on target identification and validation, through to later stage applications progressing therapeutic opportunities into clinical settings.

right
Deadline: 
Wednesday, July 3, 2019 - 3:00pm to Tuesday, September 3, 2019 - 3:00pm

The Mark Foundation for Cancer Research (MFCR), The Leukemia & Lymphoma Society (LLS), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program, a new research award program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development of improved methods for detecting and monitoring cancer progression, and the identification of novel therapeutic targets.

right
Deadline: 
Tuesday, June 11, 2019 - 1:45pm to Friday, June 21, 2019 - 5:00pm
Sanofi, a global biopharmaceutical company, is pleased to announce its 5th call for iAward pre-proposals. To date, the iAward program has attracted approximately 900 pre-proposals of which 230 have been invited back as Detailed Proposals.

Pages